Looking at options history for Vertex Pharmaceuticals (NASDAQ: VRTX) we detected 10 trades. If we consider the specifics of ...

Now, it’s worth noting Stock Advisor's total average return is 1,061% — a market-crushing outperformance compared to 192% for ...

Q. Journavx works for me! I rarely need an opioid like Norco (hydrocodone and acetaminophen) or an NSAID like Celebrex when I’m on it. Now my pain specialist says it is limited to three months a year.

The company had to abandon the development of a medicine for type 1 diabetes (T1D), while another therapy in development for acute pain failed a phase 2 study. The biotech company also encountered ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

Fibromyalgia research is progressing as scientists better understand the drivers of chronic pain and regulators push for non-narcotic solutions. The January approval of Journavx, ...

These five stocks are underperforming the S&P 500 in 2025, but have what it takes to reward investors over the long term.

I deem today’s topic, a new medication for acute pain, so important that I believe would be remiss if I did not write about ...

Boston Celtics star Jayson Tatum was forced to accept some harsh new realities — both on and off the court — after rupturing ...

An Achilles tendon rupture is one of the most challenging injuries. Tatum is opening up about a new FDA-approved medication ...

NBA star Jayson Tatum of the Boston Celtics opens up about rupturing his Achilles tendon during the Eastern Conference ...